Cargando…
New Treatment Options for Advanced Gastroesophageal Tumours: Mature for the Current Practice?
Several clinical trials attempted to identify novel treatment options for advanced gastroesophageal tumours in first, second and further lines. Although results of targeted therapy regimens were mainly disappointing, novel immunotherapy agents showed promising activity, which led to their approval i...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072704/ https://www.ncbi.nlm.nih.gov/pubmed/32012895 http://dx.doi.org/10.3390/cancers12020301 |